Angiotensin II Regulation of the Na+ Pump Involves the Phosphatidylinositol-3 Kinase and p42/44 Mitogen-Activated Protein Kinase Signaling Pathways in Vascular Smooth Muscle Cells

Endocrinology

Volumn 145, Issue 3, 2004, Pages 1151-1160

  Isenovic, Esma R ^b   Jacobs, David B ^b   Kedees, Mamdouh H ^b   Sha, Quan ^b   Milivojevic, Nikola ^b   Kawakami, Kiyoshi ^c   Gick, Gregory ^b   Sowers, James R ^a,d  

^a University of Missouri   (United States)

^b SUNY DOWNSTATE MEDICAL CENTER   (United States)

^c JICHI MEDICAL UNIVERSITY   (Japan)

^d Health Sciences Center Division of Nephrology Department of Internal Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; 1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM) ALPHA1; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM) BETA1; ADENOSINE TRIPHOSPHATASE (POTASSIUM); AMILORIDE; ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; LOSARTAN; LY 29404; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PROTEIN P85; PROTEIN SUBUNIT; SODIUM; SODIUM PROTON EXCHANGE PROTEIN; UNCLASSIFIED DRUG; WORTMANNIN;

ANIMAL CELL; ANIMAL CELL CULTURE; ARTICLE; CONTROLLED STUDY; DNA TRANSCRIPTION; DRUG EFFECT; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; ENZYME REGULATION; GENE ACTIVITY; GENETIC TRANSFECTION; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTON TRANSPORT; RAT; SIGNAL TRANSDUCTION; SODIUM TRANSPORT; UPREGULATION; VASCULAR SMOOTH MUSCLE;

1-PHOSPHATIDYLINOSITOL 3-KINASE; AMILORIDE; ANGIOTENSIN II; ANIMALS; ANTIHYPERTENSIVE AGENTS; AORTA, THORACIC; BIOLOGICAL TRANSPORT; CELLS, CULTURED; DIURETICS; LOSARTAN; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; MUSCLE, SMOOTH, VASCULAR; NA(+)-K(+)-EXCHANGING ATPASE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ANGIOTENSIN, TYPE 1; TRANSCRIPTION, GENETIC; VASOCONSTRICTOR AGENTS;

EID: 1442299153     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/en.2003-0100     Document Type: Article

References (42)

1. De Gasparo M, Catt KJ, Inagami T, Wright JW, Unger T 2001 International Union of Pharmacology. XXIII. The angiotensin II receptors. Pharmacol Rev 52:415-472
2. Kaschina E, Unger T 2003 Angiotensin AT1/AT2 receptors: regulation, signaling and function. Blood Press 12:70-88
3. Berk B, Duff J, Marrero MI 1996 Angiotensin II signal transduction in vascular smooth muscle. In: Sowers JR, ed. Endocrinology of the vasculature. Totowa, NJ: Humana Press; 187-204
4. Regitz-Zagrosek V, Neub M, Holzmeister J 1996 Molecular biology of angiotensin receptors and their role in human cardiovascular disease. J Mol Med 74:233-251
5. Rabkin SW, Goulsouliak V, Kong JY 1997 Angiotensin II induces activation of phosphatidylinositol 3-kinase in cardiomyocytes. J Hypertens 15:891-899
6. Saad MJA, Velloso LA, Carvalho CRO 1995 Angiotensin II induces tyrosine phosphorylation of insulin receptor substrate 1 and its association with phosphatidylinositol 3-kinase in rat heart. Biochem J 310:741-744
7. Funaki M, Katagiri H, Inukai K, Kikuchi M, Asano T 2000 Structure and function of phosphatidylinositol-3, 4 kinase. Cell Signal 12:135-142
8. Hemmings BA 1997 Ptdlns (3, 4, 5) P3 gets its message across. Science 277: 534-567
9. Viedt C, Soto U, Krieger-Brauer HI, Fei J, Elsing C, Kubler W, Kreuzer J 2000 Differential activation of mitogen-activated protein kinases in smooth muscle cells by angiotensin II. Arterioscler Thromb Vasc Biol 20:940-948
10. Shah BH, Reyes J, Yesilkaya A, Catt KJ 2002 Independence of angiotensin II-induced MAP kinase activation from angiotensin type 1 receptor internalization in clone 9 hepatocytes. Mol Endocrinol 16:610-620
11. Minden A, Lin A, McMahon M, Lange-Carter C, Derijard B, Davis RJ, Johnson GL, Karin M 1994 Differential activation of ERK and JNK mitogen-activated protein kinases by Raf-1 and MEKK. Science 266:1719-1723
12. Hill CS, Treisman R 1995 Transcriptional regulation by extracellular signals: mechanisms and specificity. Cell 80:199-211
13. +-ATPase: heterogeneity in structure, diversity in function. Am J Physiol 275:F633-F650
14. +-ATPase isozymes. J Biol Chem 275:1976-1986
15. +-adenosine triphosphatase regulation in hypertrophied vascular smooth muscle cells. Hypertension 20:144-150
16. + pump activity in cultures of smooth muscle from rat aorta. Proc Natl Acad Sci USA 79:1438-1442
17. Isenovic RE, Meng Y, Divald A, Milivojevic N, Sowers JR 2003 Role of PI3K/Akt pathway in angiotensin II and insulin-like growth factor-1 modulation of nitric oxide synthase in vascular smooth muscle cells. Endocrine 19:287-291
18. Standley PR, Zhang F, Ram JL, Zemel MB, Sowers JR 1991 Insulin attenuates vasopressin-induced calcium transients and a voltage-dependent calcium response in rat vascular smooth muscle cells. J Clin Invest 88:1230-1236
19. +-ATPase in rat arterial smooth muscle. Am J Physiol 273:E113-E121
20. 1 subunit gene promoter is composed of multiple cis elements to which common and cell type-specific factors bind. Mol Cell Biol 12:4046-4055
21. Isenovic E, Muniyappa R, Milivojevic N, Rao Y, Sowers, J 2001 Role of PI3-Kinase in isoproterenol and IGF-1 induced ecNOS activity. Biochem Biophys Res Commun 285:954-958
22. + regulates Na, K-ATPase α1 and β1 gene transcription in rat cardiac myocytes. Am J Hypertens 7:96-99
23. Favata MF, Horiuchi KY, Manos EJ, Daulerio AJ, Stradley DA, Feeser WS, Van Dyk DE, Pitts WJ, Earl RA, Hobbs F, Copeland RA, Magolda RL, Scherle PA, Trzaskos JM 1998 Identification of a novel inhibitor of mitogen-activated protein kinase kinase. J Biol Chem 273:18623-18632
24. + transport in vascular smooth muscle cells in genetic hypertension. Hypertension 34:442-449
25. +-pathways. Acta Physiol Scand 171:145-151
26. 1 receptor and protein kinase C-activation. J Neurochem 74:1325-1331
27. Saward I, Zahradka P 1997 Angiotensin II activates phospholatidylinositol 3-kinase in vascular smooth muscle cells. Circ Res 81:249-257
28. Villoso LA, Folli F, Sun XJ, White MF, Saad MJA, Kahn CR 1996 Cross talk between the insulin and angiotensin signaling systems. Proc Natl Acad Sci USA 93:12490-12495
29. Folli F, Kahn CR, Hansen H, Bouchie JL, Feener EP 1997 Angiotensin II inhibits insulin signaling in aortic smooth muscle cells at multiple levels. A potential role for serine phosphorylation in insulin/ angiotensin II cross-talk. J Clin Invest 100:2158-2169
30. Muthalif MM, Karzoum AN, Gaber L, Khandekar Z, Benter FI, Saeed EA, Parmentier J, Estes A, Malik UK 2000 Angiotensin II-induced hypertension contribution of Ras GTPase mitogen-activated protein kinase and cytochrome 450 metabolites. Hypertension 36:604-609
31. +)-ATPase activity by a tyrosine phosphorylation process in rat proximal convoluted tubule. J Physiol 498:99-108
32. + ATPase in human umbilical vein endothelial cells. J Endocrinol 155:587-593
33. + ATPase activity and cell growth. J Endocrinol 173: 315-323
34. Unger T 1999 The angiotensin type 2 receptor: variations on an enigmatic theme. J Hypertension 17:1775-1786
35. Gallinat S, Busche S, Raizada MK, Sumners C 2000 The angiotensin II type 2 receptor: an enigma with multiple variations. Am J Physiol Endocrinol Metab 278:E357-E374
36. Wu L, Iwai M, Nakagami H, Li Z, Chen R, Suzuki J, Akishita M, de Gasparo M, Horiuchi M 2001 Roles of angiotensin II type 2 receptor stimulation associated with selective angiotensin II type 1 receptor blockade with valsartan in the improvement of inflammation-induced vascular injury. Circulation 104: 2716-2721
37. Weissberg PL, Little PJ, Cragoe Jr EJ, Bobik A 1987 Na-H antiport in cultured rat aortic smooth muscle: its role in cytoplasmic pH regulation. Am J Physiol 253:C193-C198
38. +-ATPase by insulin/insulin-like growth factor-I in cultured rat astrocytes. Arch Biochem Biophys 307:175-182
39. Yamamoto K, Ikeda U, Okada K, Saio T, Kawakami K, Schimada S 1994 Sodium ion-mediated regulation of Na/K-ATPase gene transcription in vascular smooth muscle cells. Cardiovasc Res 128:957-962
40. +-ATPase α2-and β2-isoforms. Am J Physiol 265:C680-C687
41. +-ATPase activity in rabbit aorta. Diabetologia 36:212-217
42. Therien AG, Blostein R 2000 Mechanisms of sodium pump regulation. Am J Physiol 279:C541-C566